These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9612289)

  • 1. In chyloptysis, SP-A affects the clearance of serum lipoproteins entering the airways.
    Alberti A; Ravenna F; Quaglino D; Luisetti M; Muraca M; Previato L; Enzi GB; Bruni R; Baritussio A
    Am J Physiol; 1998 May; 274(5):L737-49. PubMed ID: 9612289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A.
    Elhalwagi BM; Zhang M; Ikegami M; Iwamoto HS; Morris RE; Miller ML; Dienger K; McCormack FX
    Am J Respir Cell Mol Biol; 1999 Sep; 21(3):380-7. PubMed ID: 10460755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pulmonary surfactant and surfactant protein A on phagocytosis of fractionated alveolar macrophages: relationship to starvation.
    Sakai K; Kweon MN; Kohri T; Kishino Y
    Cell Mol Biol; 1992 Apr; 38(2):123-30. PubMed ID: 1571941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical modification of surfactant protein A alters high affinity binding to rat alveolar type II cells and regulation of phospholipid secretion.
    Kuroki Y; Mason RJ; Voelker DR
    J Biol Chem; 1988 Nov; 263(33):17596-602. PubMed ID: 2846572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection.
    Harrod KS; Trapnell BC; Otake K; Korfhagen TR; Whitsett JA
    Am J Physiol; 1999 Sep; 277(3):L580-8. PubMed ID: 10484466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury.
    Bridges JP; Davis HW; Damodarasamy M; Kuroki Y; Howles G; Hui DY; McCormack FX
    J Biol Chem; 2000 Dec; 275(49):38848-55. PubMed ID: 10969075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages.
    Gaynor CD; McCormack FX; Voelker DR; McGowan SE; Schlesinger LS
    J Immunol; 1995 Dec; 155(11):5343-51. PubMed ID: 7594549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages.
    Benne CA; Benaissa-Trouw B; van Strijp JA; Kraaijeveld CA; van Iwaarden JF
    Eur J Immunol; 1997 Apr; 27(4):886-90. PubMed ID: 9130640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of proteinosis surfactant proteins on the viability of rat alveolar macrophages.
    Shen HQ; Duan CX; Li ZY; Suzuki Y
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1679-87. PubMed ID: 9372693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage.
    Alberti A; Luisetti M; Braschi A; Rodi G; Iotti G; Sella D; Poletti V; Benori V; Baritussio A
    Am J Respir Crit Care Med; 1996 Sep; 154(3 Pt 1):817-20. PubMed ID: 8810625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary surfactant and inflammation in septic adult mice: role of surfactant protein A.
    Malloy JL; Veldhuizen RA; McCormack FX; Korfhagen TR; Whitsett JA; Lewis JF
    J Appl Physiol (1985); 2002 Feb; 92(2):809-16. PubMed ID: 11796696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of surfactant proteins A and D in innate lung defense against pathogens.
    van Golde LM
    Biol Neonate; 1995; 67 Suppl 1():2-17. PubMed ID: 7647156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant-associated proteins (SP-A, SP-B) are increased proportionally to alveolar phospholipids in sheep silicosis.
    Lesur O; Veldhuizen RA; Whitsett JA; Hull WM; Possmayer F; Cantin A; Bégin R
    Lung; 1993; 171(2):63-74. PubMed ID: 8426464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.
    Atochina EN; Beck JM; Scanlon ST; Preston AM; Beers MF
    J Lab Clin Med; 2001 Jun; 137(6):429-39. PubMed ID: 11385364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of surfactant protein A with cellular myosin.
    Michelis D; Kounnas MZ; Argraves WS; Sanford ED; Borchelt JD; Wright JR
    Am J Respir Cell Mol Biol; 1994 Dec; 11(6):692-700. PubMed ID: 7946398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14.
    Sano H; Sohma H; Muta T; Nomura S; Voelker DR; Kuroki Y
    J Immunol; 1999 Jul; 163(1):387-95. PubMed ID: 10384140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant protein A is degraded by alveolar macrophages.
    Bates SR; Fisher AB
    Am J Physiol; 1996 Aug; 271(2 Pt 1):L258-66. PubMed ID: 8770065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of canine surfactant protein (SP-A) on the respiratory burst of phagocytic cells.
    Weber H; Heilmann P; Meyer B; Maier KL
    FEBS Lett; 1990 Sep; 270(1-2):90-4. PubMed ID: 2171995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages.
    Pasula R; Downing JF; Wright JR; Kachel DL; Davis TE; Martin WJ
    Am J Respir Cell Mol Biol; 1997 Aug; 17(2):209-17. PubMed ID: 9271309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased surfactant protein A content in human alveolar macrophages in hypersensitivity pneumonitis.
    Guzman J; Wang YM; Kalaycioglu O; Schoenfeld B; Hamm H; Bartsch W; Costabel U
    Acta Cytol; 1992; 36(5):668-73. PubMed ID: 1523923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.